Ingevity Corp Files 8-K on Financial Condition and Operations

Ticker: NGVT · Form: 8-K · Filed: 2024-02-21T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, operations, 8-K

TL;DR

**Ingevity just dropped an 8-K on its financial results and operations, so keep an eye out for details.**

AI Summary

Ingevity Corp filed an 8-K on February 21, 2024, reporting on its results of operations and financial condition. The filing indicates that the company, incorporated in Delaware with IRS number 47-4027764, is headquartered at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405. This 8-K serves to update stakeholders on the company's financial performance and current operational status.

Why It Matters

This filing provides a mandatory update on Ingevity's financial health and operational performance, offering transparency to investors and the market.

Risk Assessment

Risk Level: low — This 8-K is a routine filing for reporting financial condition and operations, not indicating any immediate specific risks.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by Ingevity Corp?

The purpose of this 8-K filing is to report on the results of operations and financial condition, as well as financial statements and exhibits, as per Item Information.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on February 21, 2024.

What is the state of incorporation for Ingevity Corporation?

Ingevity Corporation is incorporated in Delaware.

What is the business address of Ingevity Corporation?

The business address of Ingevity Corporation is 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.

What is Ingevity Corp's IRS Employer Identification Number?

Ingevity Corp's IRS Employer Identification Number is 47-4027764.

Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-02-21 16:24:16

Key Financial Figures

Filing Documents

02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On February 21, 2024 , Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and twelve months ended December 31, 2023, which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such other information including Ingevity slide presentations. The information contained in Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press release dated February 21, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ MARY DEAN HALL Mary Dean Hall Executive Vice President and Chief Financial Officer Date: February 21, 2024

View on Read The Filing